cDNA microarray profiling of rat cholangiocarcinoma induced by thioacetamide

Area of Science:

• Hepatobiliary pathology
• Cancer genomics
• Animal models of disease

Background:

• Cholangiocarcinoma (CCA) is a significant global health concern.
• CCA development is a complex, multistep process.
• Existing models do not fully recapitulate human CCA, particularly the mass-forming type.

Purpose of the Study:

• To establish a thioacetamide (TAA)-induced rat model for cholangiocarcinoma (CCA).
• To analyze gene expression profiles in this TAA-induced CCA model.
• To identify potential biomarkers and therapeutic targets for CCA.

Main Methods:

• Oral administration of thioacetamide (TAA) to Sprague-Dawley rats for 24 weeks to induce CCA.
• Whole rat genomic oligo microarray analysis to compare gene expression in CCA and non-cancerous liver tissues.
• Validation of key differentially expressed genes using quantitative real-time PCR and immunohistochemistry.

Main Results:

• The TAA-induced rat model demonstrated histological progression similar to human CCA.
• Microarray analysis revealed 10,427 differentially expressed genes in CCA tissues (8,318 upregulated, 3,489 downregulated).
• Specific genes like CLCA3, COL1A2, DCN, GLIPr2, NID1, CYP2C7, and SLC10A1 showed altered expression, validated by PCR and protein analysis.

Conclusions:

• The TAA-induced rat model effectively mimics human CCA, providing a valuable tool for research.
• Gene expression profiling offers insights into CCA carcinogenesis.
• Identified differentially expressed genes may serve as novel biomarkers for CCA diagnosis and therapeutic targets.